Federal Circuit Boosts Impax In Aventis Patent Suit
Law360 (November 21, 2006, 12:00 AM EST) -- A federal appeals court has given generic drug maker Impax Laboratories Inc. another chance to strike down a hotly contested patent for the Lou Gehrig's disease treatment held by rival Aventis...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
